This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) rose 1.92% to $667.56 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 2.02% to 4,088.85 and the Dow Jones Industrial Average rising 1.34% to 32,654.59. This was the stock's fourth consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $79.86 short of its 52-week high ($747.42), which the company reached on April 8th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.42% to $178.82, Novartis AG ADR (NOVN.EB) rose 0.13% to $87.92, and Amgen Inc. (AMGN) rose 0.61% to $245.35. Trading volume (571,714) remained 98,989 below its 50-day average volume of 670,703.
Data source: Dow Jones Market Data, FactSet. Data compiled May 17, 2022.
(END) Dow Jones Newswires
May 17, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.